Natixis’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20M | Sell |
277,825
-78,316
| -22% | -$6.03M | 0.07% | 193 |
|
|
2025
Q4 | $28.3M | Buy |
356,141
+21,971
| +7% | +$1.73M | 0.1% | 150 |
|
|
2025
Q3 | $25.2M | Buy |
334,170
+212,925
| +176% | +$14.6M | 0.12% | 158 |
|
|
2025
Q2 | $8.36M | Buy |
121,245
+31,659
| +35% | +$2.08M | 0.04% | 265 |
|
|
2025
Q1 | $6.07M | Sell |
89,586
-11,763
| -12% | -$704K | 0.03% | 281 |
|
|
2024
Q4 | $4.55M | Sell |
101,349
-5,602
| -5% | -$314K | 0.03% | 356 |
|
|
2024
Q3 | $6.73M | Buy |
106,951
+51,628
| +93% | +$3.01M | 0.04% | 280 |
|
|
2024
Q2 | $3.27M | Sell |
55,323
-149,490
| -73% | -$9.35M | 0.02% | 341 |
|
|
2024
Q1 | $16.3M | Sell |
204,813
-213,042
| -51% | -$16.3M | 0.08% | 171 |
|
|
2023
Q4 | $33M | Sell |
417,855
-10,967
| -3% | -$781K | 0.24% | 98 |
|
|
2023
Q3 | $29.9M | Sell |
428,822
-1,160,674
| -73% | -$82.2M | 0.23% | 96 |
|
|
2023
Q2 | $110M | Buy |
1,589,496
+1,045,838
| +192% | +$74.4M | 0.89% | 19 |
|
|
2023
Q1 | $40.4M | Buy |
543,658
+264,041
| +94% | +$22.1M | 0.36% | 65 |
|
|
2022
Q4 | $26.1M | Buy |
279,617
+112,121
| +67% | +$10.8M | 0.15% | 134 |
|
|
2022
Q3 | $16M | Sell |
167,496
-99,715
| -37% | -$9.87M | 0.07% | 199 |
|
|
2022
Q2 | $24.8M | Buy |
267,211
+42,142
| +19% | +$4.11M | 0.09% | 145 |
|
|
2022
Q1 | $22.8M | Sell |
225,069
-398,651
| -64% | -$41.9M | 0.08% | 235 |
|
|
2021
Q4 | $64.3M | Buy |
623,720
+377,355
| +153% | +$34.9M | 0.22% | 84 |
|
|
2021
Q3 | $20.9M | Sell |
246,365
-266,010
| -52% | -$22.3M | 0.07% | 229 |
|
|
2021
Q2 | $42.8M | Sell |
512,375
-455,594
| -47% | -$37.3M | 0.19% | 108 |
|
|
2021
Q1 | $72.8M | Buy |
967,969
+638,077
| +193% | +$46.5M | 0.24% | 89 |
|
|
2020
Q4 | $22.5M | Buy |
329,892
+213,897
| +184% | +$13.9M | 0.08% | 236 |
|
|
2020
Q3 | $6.72M | Sell |
115,995
-224,662
| -66% | -$14M | 0.05% | 229 |
|
|
2020
Q2 | $22.1M | Buy |
340,657
+78,171
| +30% | +$4.92M | 0.17% | 113 |
|
|
2020
Q1 | $15.6M | Sell |
262,486
-241,376
| -48% | -$16.1M | 0.12% | 155 |
|
|
2019
Q4 | $37.1M | Buy |
503,862
+331,961
| +193% | +$23.3M | 0.23% | 117 |
|
|
2019
Q3 | $10.8M | Buy |
171,901
+25,618
| +18% | +$1.52M | 0.07% | 248 |
|
|
2019
Q2 | $7.97M | Buy |
146,283
+100,774
| +221% | +$5.43M | 0.06% | 253 |
|
|
2019
Q1 | $2.43M | Sell |
45,509
-583,009
| -93% | -$36M | 0.02% | 479 |
|
|
2018
Q4 | $41.2M | Sell |
628,518
-1,222,042
| -66% | -$91.2M | 0.34% | 76 |
|
|
2018
Q3 | $146M | Buy |
1,850,560
+556,575
| +43% | +$39.8M | 0.84% | 27 |
|
|
2018
Q2 | $82.6M | Buy |
1,293,985
+1,074,010
| +488% | +$70.8M | 0.44% | 57 |
|
|
2018
Q1 | $13.6M | Buy |
219,975
+187,201
| +571% | +$13.4M | 0.08% | 217 |
|
|
2017
Q4 | $2.38M | Buy |
+32,774
| New | +$2.38M | 0.02% | 386 |
|
|
2017
Q3 | – | Sell |
-16,582
| Closed | -$1.33M | – | 1263 |
|
|
2017
Q2 | $1.33M | Buy |
16,582
+12,021
| +264% | +$949K | 0.02% | 377 |
|
|
2017
Q1 | $358K | Sell |
4,561
-87,713
| -95% | -$7M | ﹤0.01% | 622 |
|
|
2016
Q4 | $7.28M | Buy |
92,274
+11,821
| +15% | +$956K | 0.08% | 219 |
|
|
2016
Q3 | $7.16M | Buy |
+80,453
| New | +$7.59M | 0.08% | 165 |
|
|
2015
Q2 | – | Sell |
-8,196
| Closed | -$846K | – | 384 |
|
|
2015
Q1 | $846K | Sell |
8,196
-2,814
| -26% | -$285K | 0.01% | 250 |
|
|
2014
Q4 | $1.06M | Sell |
11,010
-15,110
| -58% | -$1.33M | 0.01% | 223 |
|
|
2014
Q3 | $2.08M | Buy |
26,120
+11,639
| +80% | +$918K | 0.03% | 202 |
|
|
2014
Q2 | $1.09M | Sell |
14,481
-5,057
| -26% | -$382K | 0.01% | 302 |
|
|
2014
Q1 | $1.46M | Buy |
19,538
+5,116
| +35% | +$361K | 0.02% | 281 |
|
|
2013
Q4 | $1.03M | Sell |
14,422
-560,775
| -97% | -$36M | 0.01% | 350 |
|
|
2013
Q3 | $32.6M | Buy |
+575,197
| New | +$34.3M | 0.35% | 75 |
|
Other funds holding CVS
VCM
VPM
Natixis's CVS Position: Q1 2026 in Review
Natixis reduced its CVS Health (CVS) stake by 22% in Q1 2026, selling an estimated $6.03M and leaving 277,825 shares worth $20M. The position accounts for 0.07% of the portfolio, ranked #193.
Natixis first reported a position in CVS in Q3 2013 and has held it in 45 quarters since. The position peaked at $146M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Natixis held 277,825 shares of CVS Health worth $20M as of Q1 2026.
- Natixis sold 78,316 CVS Health shares in Q1 2026, an estimated $6.03M.
- CVS Health made up 0.07% of Natixis's portfolio in Q1 2026, its #193 holding.
- Natixis first reported a position in CVS Health in Q3 2013 and has held it in 45 quarters since.
- Natixis's CVS Health position peaked at $146M in Q3 2018.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.